Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity

BJU International

Volumn 116, Issue 4, 2015, Pages 596-603

  Steinberger, Emily ^a   Kollmeier, Marisa ^a   McBride, Sean ^a   Novak, Caroline ^a   Pei, Xin ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

cigarette smoking; distant metastases; prostate cancer; radiotherapy; toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION HAZARD; SMOKING; SMOKING CESSATION; SMOKING HABIT; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; ADVERSE EFFECTS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

AGED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SMOKING;

EID: 84941192999     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12969     Document Type: Article

References (18)

1. Daniell HW,. A worse prognosis for smokers with prostate cancer. J Urol 1995; 154: 153-157
2. Giovannucci E, Rimm EB, Ascherio A, et al. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev 1999; 8: 277-282
3. Hickey K, Do KA, Green A,. Smoking and prostate cancer. Epidemiol Rev 2001; 23: 115-125
4. Huncharek M, Haddock KS, Reid R, Kupelnick B,. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010; 100: 693-701
5. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E,. Smoking and prostate cancer survival and recurrence. JAMA 2011; 305: 2548-2555
6. Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath CW Jr,. Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol 1997; 145: 466-475
7. Watters JL, Park Y, Hollenbeck A, Schatzkin A, Albanes D,. Cigarette smoking and prostate cancer in a prospective US cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2427-2435
8. Cox DR,. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220
9. Morgan G, Schnoll RA, Alfano CM, et al. National cancer institute conference on treating tobacco dependence at cancer centers. J Oncol Pract 2011; 7: 178-182
10. Byar D, Corle D,. Analysis of prognostic factors for prostatic cancer in the VACURG studies. In, Denis L, Murphy G, Prout G, et al eds, Controlled Clinical Trials in Urologic Oncology, New York, NY: Raven Press, 1984: 147-169
11. Ferson M, Edwards A, Lind A, Milton GW, Hersey P,. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979; 23: 603-609
12. Gerrard JW, Heiner DC, Ko CG, Mink J, Meyers A, Dosman JA,. Immunoglobulin levels in smokers and non-smokers. Ann Allergy 1980; 44: 261-262
13. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001; 7: 833-839
14. Jensen JA, Goodson WH, Hopf HW, Hunt TK,. Cigarette smoking decreases tissue oxygen. Arch Surg 1991; 126: 1131-1134
15. Moeller BJ, Richardson RA, Dewhirst MW,. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007; 26: 241-248
16. Hennessey D, Martin LM, Atzberger A, Lynch TH, Hollywood D, Marignol L,. Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells. Urol Oncol 2013; 31: 1106-1116
17. Bellizzi KM, Rowland JH, Jeffery DD, McNeel T,. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005; 23: 8884-8893
18. Simmons VN, Litvin EB, Patel RD, et al. Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns 2009; 77: 398-403